Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / COMMON STOCK, PAR V ALUE $0.001 PER SHARE
-
Shares outstanding
-
74.9M
-
Number of holders
-
77
-
Total 13F shares, excl. options
-
11.4M
-
Shares change
-
+545K
-
Total reported value, excl. options
-
$77.9M
-
Value change
-
+$3.07M
-
Put/Call ratio
-
0.55
-
Number of buys
-
38
-
Number of sells
-
-29
-
Price
-
$6.86
Significant Holders of CorMedix Inc. - COMMON STOCK, PAR V ALUE $0.001 PER SHARE (CRMD) as of Q2 2021
95 filings reported holding CRMD - CorMedix Inc. - COMMON STOCK, PAR V ALUE $0.001 PER SHARE as of Q2 2021.
CorMedix Inc. - COMMON STOCK, PAR V ALUE $0.001 PER SHARE (CRMD) has 77 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.4M shares
of 74.9M outstanding shares and own 15.15% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2.49M shares), VANGUARD GROUP INC (1.74M shares), Elliott Investment Management L.P. (1.55M shares), CREDIT SUISSE AG/ (751K shares), GEODE CAPITAL MANAGEMENT, LLC (631K shares), STATE STREET CORP (631K shares), NORTHERN TRUST CORP (361K shares), Cresset Asset Management, LLC (330K shares), MORGAN STANLEY (304K shares), and Nuveen Asset Management, LLC (226K shares).
This table shows the top 77 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.